Legis Daily

Exposing Congressional Drug Abuse Act

USA119th CongressHCONRES-35| House 
| Updated: 6/5/2025
Clay Higgins

Clay Higgins

Republican Representative

Louisiana

Committee on House Administration

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This concurrent resolution establishes a program requiring all Members of the House of Representatives and the Senate to participate in random drug testing for illegal controlled substances. Under this program, each Member would be subject to one random drug test per term, conducted periodically without advance notice or individualized suspicion. The resolution defines a "confirmed positive result" as one that undergoes an initial positive test, is confirmed by a second test using a different chemical process, and is certified by a medical review officer, specifically excluding legal or prescribed medications. Upon a confirmed positive result, the information would be provided to the Member involved and to the relevant ethics committee (House Ethics Committee or Senate Select Committee on Ethics) for necessary review. Importantly, if a Member refuses to participate in the program, their identity will be publicly disclosed by the respective ethics committee, which may also take other appropriate action. Additionally, each Member is responsible for reimbursing the House or Senate for the cost of their individual random drug test.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HCONRES 116-22
Exposing Congressional Drug Abuse Act
Jun 5, 2025
Submitted in House
Jun 5, 2025
Referred to the House Committee on House Administration.
  • Bill from Previous Congress

    HCONRES 116-22
    Exposing Congressional Drug Abuse Act


  • June 5, 2025
    Submitted in House


  • June 5, 2025
    Referred to the House Committee on House Administration.

Congress

Exposing Congressional Drug Abuse Act

USA119th CongressHCONRES-35| House 
| Updated: 6/5/2025
This concurrent resolution establishes a program requiring all Members of the House of Representatives and the Senate to participate in random drug testing for illegal controlled substances. Under this program, each Member would be subject to one random drug test per term, conducted periodically without advance notice or individualized suspicion. The resolution defines a "confirmed positive result" as one that undergoes an initial positive test, is confirmed by a second test using a different chemical process, and is certified by a medical review officer, specifically excluding legal or prescribed medications. Upon a confirmed positive result, the information would be provided to the Member involved and to the relevant ethics committee (House Ethics Committee or Senate Select Committee on Ethics) for necessary review. Importantly, if a Member refuses to participate in the program, their identity will be publicly disclosed by the respective ethics committee, which may also take other appropriate action. Additionally, each Member is responsible for reimbursing the House or Senate for the cost of their individual random drug test.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HCONRES 116-22
Exposing Congressional Drug Abuse Act
Jun 5, 2025
Submitted in House
Jun 5, 2025
Referred to the House Committee on House Administration.
  • Bill from Previous Congress

    HCONRES 116-22
    Exposing Congressional Drug Abuse Act


  • June 5, 2025
    Submitted in House


  • June 5, 2025
    Referred to the House Committee on House Administration.
Clay Higgins

Clay Higgins

Republican Representative

Louisiana

Committee on House Administration

Congress

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted